Literature DB >> 34923592

Approach of probiotics in mental health as a psychobiotics.

Heenu Sharma1, Jasveen Bajwa2.   

Abstract

Probiotics are those beneficial microbes that confer various health benefits to humans when integrated in diet in adequate amount. They possess vital metabolites having nutritional and therapeutic properties which provide countless health benefits. Scientific discoveries demonstrated that these living microbial consortiums may exert impact on anxiety, depression, cognitive functions, stress responses and behaviours. Those probiotics that controls the functioning or actions of central nervous system (CNS) conciliated by the gut brain axis (GBA) through neural, humoral and metabolic pathways to ameliorate the gastrointestinal activity as well as anti-depressant and anxiolytic capacity are known as psychobiotics. Few evidences have confirmed the remedial effects of psychobiotics against neurological conditions or disorders. So, therapeutic approach of psychobiotics leads to the future possibilities in the development field for researchers. This review article describes the potential role and mechanism of action of psychobiotics.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Anti-depressant; Gut brain axis; Neurological; Probiotics; Psychobiotics

Mesh:

Year:  2021        PMID: 34923592     DOI: 10.1007/s00203-021-02622-x

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  30 in total

Review 1.  Microbes and the gut-brain axis.

Authors:  P Bercik; S M Collins; E F Verdu
Journal:  Neurogastroenterol Motil       Date:  2012-03-08       Impact factor: 3.598

Review 2.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

3.  Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.

Authors:  Jürgen Berg; Manfred Roch; Jennifer Altschüler; Christine Winter; Anne Schwerk; Andreas Kurtz; Barbara Steiner
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

4.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve.

Authors:  Javier A Bravo; Paul Forsythe; Marianne V Chew; Emily Escaravage; Hélène M Savignac; Timothy G Dinan; John Bienenstock; John F Cryan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

5.  Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.

Authors:  Afifa Ait-Belgnaoui; Henri Durand; Christel Cartier; Gilles Chaumaz; Hélène Eutamene; Laurent Ferrier; Eric Houdeau; Jean Fioramonti; Lionel Bueno; Vassilia Theodorou
Journal:  Psychoneuroendocrinology       Date:  2012-04-26       Impact factor: 4.905

6.  The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson's Disease: A Randomized, Double-blind, PlaceboControlled Trial.

Authors:  Shokoofeh Borzabadi; Shahrbanoo Oryan; Akram Eidi; Esmat Aghadavod; Reza Daneshvar Kakhaki; Omid Reza Tamtaji; Mohsen Taghizadeh; Zatollah Asemi
Journal:  Arch Iran Med       Date:  2018-07-01       Impact factor: 1.354

Review 7.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.

Authors:  Patrice D Cani; Melania Osto; Lucie Geurts; Amandine Everard
Journal:  Gut Microbes       Date:  2012-05-14

8.  Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.

Authors:  Afifa Ait-Belgnaoui; Isabelle Payard; Claire Rolland; Cherryl Harkat; Viorica Braniste; Vassillia Théodorou; Thomas A Tompkins
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

9.  SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model.

Authors:  Laura Bonfili; Valentina Cecarini; Massimiliano Cuccioloni; Mauro Angeletti; Sara Berardi; Silvia Scarpona; Giacomo Rossi; Anna Maria Eleuteri
Journal:  Mol Neurobiol       Date:  2018-02-28       Impact factor: 5.590

10.  Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial.

Authors:  Azadeh Agahi; Gholam Ali Hamidi; Reza Daneshvar; Mostafa Hamdieh; Masoud Soheili; Azam Alinaghipour; Seyyed Mohammad Esmaeili Taba; Mahmoud Salami
Journal:  Front Neurol       Date:  2018-08-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.